Activity-based proteome profiling of potential cellular targets of orlistat - An FDA-approved drug with anti-tumor activities
10.1021/ja907716f
Saved in:
Main Authors: | Yang, P.-Y., Ngai, M.H., Lear, M.J., Wenk, M.R., Yao, S.Q., Liu, K. |
---|---|
Other Authors: | BIOCHEMISTRY |
Format: | Article |
Published: |
2011
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/28794 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Activity-based proteome profiling of potential cellular targets of orlistat - An FDA-approved drug with anti-tumor activities
by: Yang, P.-Y., et al.
Published: (2014) -
Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent
by: Yang, P.-Y., et al.
Published: (2014) -
Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti trypanosoma brucei agent
by: Ngai, Mun Hong, et al.
Published: (2013) -
Chemical modification and organelle-specific localization of Orlistat-like natural-product-based probes
by: Yang, P.-Y., et al.
Published: (2014) -
Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection
by: Loe, MWC, et al.
Published: (2020)